Integra LifeSciences to Host Second Quarter 2021 Financial Results Conference Call on July 28, 2021
Integra LifeSciences Holdings Corporation (NASDAQ: IART) will release its second quarter 2021 financial results on July 28, 2021, before market open.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Integra LifeSciences Holdings Corporation (NASDAQ: IART) will release its second quarter 2021 financial results on July 28, 2021, before market open. The management team will host a conference call at 8:30 a.m. ET, accessible by dialing (800) 367-2403 and using passcode 3706513. A simultaneous webcast will be available on the company’s website. A replay will be accessible until August 7, 2021. Integra is a global leader in regenerative tissue technologies and neurosurgical solutions, providing a comprehensive portfolio of high-quality brands aimed at enhancing patient care.
Positive
- Scheduled earnings release for Q2 2021 indicates ongoing transparency with investors.
- Offers a comprehensive portfolio of high-quality brands, potentially boosting market position.
Negative
- None.
Details
News Market Reaction – IART
The recorded move for IART in the trading session of this news was -0.25%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
PRINCETON, N.J., July 08, 2021 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will release second quarter 2021 financial results on Wednesday, July 28, 2021 prior to market open. In conjunction with the earnings release, Integra’s management team will host a conference call at 8:30 a.m. ET.
The live call is accessible by dialing (800) 367-2403 and using the passcode 3706513. A simultaneous webcast of the call will be available via the Company’s website at www.integralife.com.
A webcast replay of the call can be accessed through the Investor Relations homepage of Integra's website at www.integralife.com. A replay of the call will be available until August 7, 2021 by dialing (888) 203-1112 and using the passcode 3706513.
About Integra LifeSciences
Integra LifeSciences is a global leader in regenerative tissue technologies and neurosurgical solutions dedicated to limiting uncertainty for clinicians, so they can focus on providing the best patient care. Integra offers a comprehensive portfolio of high quality, leadership brands that include AmnioExcel®, Bactiseal®, CerebroFlo®, CereLink® Certas® Plus, Codman®, CUSA®, Cytal®, DuraGen®, DuraSeal®, Gentrix®, ICP Express®, Integra®, MatriStem® UBM, MAYFIELD®, MediHoney®, MicroFrance®, MicroMatrix®, PriMatrix®, SurgiMend®, TCC-EZ® and VersaTru®. For the latest news and information about Integra and its products, please visit www.integralife.com.
Investor Relations:
Michael Beaulieu
(609) 529-4812
michael.beaulieu@integralife.com
Media Contact:
Laurene Isip
(609) 208-8121
laurene.isip@integralife.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.